• Published On : Nov-2016 |
  • Pages : 145 Pages |
  • Format :

1. Executive Summary

2. Market Introduction
   2.1. Market Taxonomy
   2.2. Market Definition

3. Global Neuropathic Pain Market Analysis Scenario
   3.1. Pricing Analysis
        3.1.1. Pricing Assumptions
        3.1.2. Price Projections Per Region
   3.2. Market Size (US$ Mn) and Forecast
        3.2.1. Market Size and Y-o-Y Growth
        3.2.2. Absolute $ Opportunity

4. Market Dynamics
   4.1. Macro-economic Factors
   4.2. Drivers
        4.2.1. Supply Side
        4.2.2. Demand Side
   4.3. Restraints
   4.4. Opportunity
   4.5. Forecast Factors – Relevance and Impact
   4.6.Pipeline Analysis of drugs for treatment of CIPN

5. Global Neuropathic Pain Market Analysis and Forecasts, By Drug Class 
   5.1. Introduction
   5.2. Basis Point Share (BPS) Analysis By Drug Class Type
   5.3. Y-o-Y Growth Projections By Drug Class Type
   5.4. Market Value Forecast By Drug Class, 2016–2024
        5.4.1. Tricyclic Antidepressant
        5.4.2. Anticonvulsants
        5.4.3. Local Anaesthesia
        5.4.4. Opioids
        5.4.5. Steroids
        5.4.6. Others
   5.5. Market Attractiveness By Drug Class 

6. Global Neuropathic Pain Market Analysis and Forecasts, By Indication 
   6.1. Introduction
   6.2. Basis Point Share (BPS) Analysis By Indication 
   6.3. Y-o-Y Growth Projections By Indication 
   6.4. Market Value Forecast By Indication, 2016–2024
        6.4.1. Diabetic Neuropathy
        6.4.2. Chemotherapy-induced Peripheral Neuropathy
        6.4.3. Others
   6.5. Market Attractiveness By Indication 

7. Global Neuropathic Pain Market Analysis and Forecasts, By Distribution Channel 
   7.1. Introduction
   7.2. Basis Point Share (BPS) Analysis By Distribution Channel 
   7.3. Y-o-Y Growth Projections By Distribution Channel 
   7.4. Market Value Forecast By Distribution Channel, 2016–2024
        7.4.1. Retail Pharmacies
        7.4.2. Drug Stores
        7.4.3. Online Pharmacies
   7.5. Market Attractiveness By Distribution Channel 

8. Global Neuropathic Pain Market Analysis and Forecasts, By Region
   8.1. Basis Point Share (BPS) Analysis By Region
   8.2. Y-o-Y Growth Projections By Region
   8.3. Market Value Forecast By Region
        8.3.1. North America 
        8.3.2. Latin America 
        8.3.3. Europe 
        8.3.4. Asia Pacific 
        8.3.5. Middle East and Africa 
   8.4. Market Attractiveness By Region

9. North America Neuropathic Pain Market Analysis and Forecast
   9.1. Introduction
        9.1.1. Basis Point Share (BPS) Analysis By Country
        9.1.2. Y-o-Y Growth Projections By Country
        9.1.3. Key Regulations
   9.2. Market Value Forecast By Drug Class, 2016–2024
        9.2.1. Tricyclic Antidepressant
        9.2.2. Anticonvulsants
        9.2.3. Local Anaesthesia
        9.2.4. Opioids
        9.2.5. Steroids
        9.2.6. Others
   9.3. Market Value Forecast By Indication, 2016–2024
        9.3.1. Diabetic Neuropathy
        9.3.2. Chemotherapy-induced Peripheral Neuropathy
        9.3.3. Others
   9.4. Market Value Forecast By Distribution Channel, 2016–2024
        9.4.1. Retail Pharmacies
        9.4.2. Drug Stores
        9.4.3. Online Pharmacies
   9.5. Market Value Forecast By Country, 2016–2024
        9.5.1. US
        9.5.2. Canada
   9.6. Market Attractiveness Analysis 
        9.6.1. By Drug Class 
        9.6.2. By Indication 
        9.6.3. By Distribution Channel 
   9.7. Drivers and Restraints: Impact Analysis 

10. Latin America Neuropathic Pain Market Analysis and Forecast
   10.1.Introduction
        10.1.1. Basis Point Share (BPS) Analysis By Country
        10.1.2. Y-o-Y Growth Projections By Country
        10.1.3. Key Regulations
   10.2.Market Value Forecast By Drug Class, 2016–2024
        10.2.1. Tricyclic Antidepressant
        10.2.2. Anticonvulsants
        10.2.3. Local Anaesthesia
        10.2.4. Opioids
        10.2.5. Steroids
        10.2.6. Others
   10.3.Market Value Forecast By Indication, 2016–2024
        10.3.1. Diabetic Neuropathy
        10.3.2. Chemotherapy-induced Peripheral Neuropathy
        10.3.3. Others
   10.4.Market Value Forecast By Distribution Channel, 2016–2024
        10.4.1. Retail Pharmacies
        10.4.2. Drug Stores
        10.4.3. Online Pharmacies
   10.5.Market Value Forecast By Country, 2016–2024
        10.5.1. Brazil
        10.5.2. Mexico
        10.5.3. Argentina
        10.5.4. Rest of Latin America
   10.6.Market Attractiveness Analysis 
        10.6.1. By Drug Class 
        10.6.2. By Indication 
        10.6.3. By Distribution Channel 
   10.7. Drivers and Restraints: Impact Analysis 

11. Europe Neuropathic Pain Market Analysis and Forecast
   11.1.Introduction
        11.1.1. Basis Point Share (BPS) Analysis By Country
        11.1.2. Y-o-Y Growth Projections By Country
        11.1.3. Key Regulations
   11.2.Market Value Forecast By Drug Class, 2016–2024
        11.2.1. Tricyclic Antidepressant
        11.2.2. Anticonvulsants
        11.2.3. Local Anaesthesia
        11.2.4. Opioids
        11.2.5. Steroids
        11.2.6. Others
   11.3.Market Value Forecast By Indication, 2016–2024
        11.3.1. Diabetic Neuropathy
        11.3.2. Chemotherapy-induced Peripheral Neuropathy
        11.3.3. Others
   11.4.Market Value Forecast By Distribution Channel, 2016–2024
        11.4.1. Retail Pharmacies
        11.4.2. Drug Stores
        11.4.3. Online Pharmacies
   11.5.Market Value Forecast By Country, 2016–2024
        11.5.1. UK
        11.5.2. France
        11.5.3. Germany
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Russia
        11.5.7. Rest of Europe
   11.6.Market Attractiveness Analysis 
        11.6.1. By Drug Class 
        11.6.2. By Indication 
        11.6.3. By Distribution Channel 
   11.7. Drivers and Restraints: Impact Analysis 

12. Asia Pacific Neuropathic Pain Market Analysis and Forecast
   12.1.Introduction
        12.1.1. Basis Point Share (BPS) Analysis By Country
        12.1.2. Y-o-Y Growth Projections By Country
        12.1.3. Key Regulations
   12.2.Market Value Forecast By Drug Class, 2016–2024
        12.2.1. Tricyclic Antidepressant
        12.2.2. Anticonvulsants
        12.2.3. Local Anaesthesia
        12.2.4. Opioids
        12.2.5. Steroids
        12.2.6. Others
   12.3.Market Value Forecast By Indication, 2016–2024
        12.3.1. Diabetic Neuropathy
        12.3.2. Chemotherapy-induced Peripheral Neuropathy
        12.3.3. Others
   12.4.Market Value Forecast By Distribution Channel, 2016–2024
        12.4.1. Retail Pharmacies
        12.4.2. Drug Stores
        12.4.3. Online Pharmacies
   12.5.Market Value Forecast By Country, 2016–2024
        12.5.1. Japan
        12.5.2. China
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
        12.5.6. 
   12.6.Market Attractiveness Analysis 
        12.6.1. By Drug Class 
        12.6.2. By Indication 
        12.6.3. By Distribution Channel 
   12.7. Drivers and Restraints: Impact Analysis 

13. Middle East and Africa Neuropathic Pain Market Analysis and Forecast
   13.1.Introduction
        13.1.1. Basis Point Share (BPS) Analysis By Country
        13.1.2. Y-o-Y Growth Projections By Country
        13.1.3. Key Regulations
   13.2.Market Value Forecast By Drug Class, 2016–2024
        13.2.1. Tricyclic Antidepressant
        13.2.2. Anticonvulsants
        13.2.3. Local Anaesthesia
        13.2.4. Opioids
        13.2.5. Steroids
        13.2.6. Others
   13.3.Market Value Forecast By Indication, 2016–2024
        13.3.1. Diabetic Neuropathy
        13.3.2. Chemotherapy-induced Peripheral Neuropathy
        13.3.3. Others
   13.4.Market Value Forecast By Distribution Channel, 2016–2024
        13.4.1. Retail Pharmacies
        13.4.2. Drug Stores
        13.4.3. Online Pharmacies
   13.5.Market Value Forecast By Country, 2016–2024
        13.5.1. South Africa
        13.5.2. UAE
        13.5.3. Rest of MEA
   13.6.Market Attractiveness Analysis 
        13.6.1. By Drug Class 
        13.6.2. By Indication 
        13.6.3. By Distribution Channel 
   13.7. Drivers and Restraints: Impact Analysis 

14. Competition Landscape
   14.1. Competition Dashboard
   14.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
        14.2.1. Pfizer, Inc.
        14.2.2. Johnson & Johnson Services, Inc.
        14.2.3. Sanofi S.A.
        14.2.4. Eli Lily and Company
        14.2.5. GlaxoSmithKline PLC
        14.2.6. Biogen Idec.
        14.2.7. Bristol-Myers Squibb
        14.2.8. Baxter Healthcare Corporation
        14.2.9 Depomed Inc.

15. Assumptions and Acronyms Used

16. Research Methodology


List of Tables

Table 01: Global Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Drug Class, 2015–2024
Table 02: Global Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Indication, 2015–2024
Table 03: Global Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 04: Global Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Region, 2015–2024
Table 05: North America Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 06: North America Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Drug Class, 2015–2024
Table 07: North America Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Indication, 2015–2024
Table 08: North America Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 09: Latin America Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 10: Latin America Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Drug Class, 2015–2024
Table 11: Latin America Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Indication, 2015–2024
Table 12: Latin America Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 13: Europe Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 14: Europe Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Drug Class, 2015–2024
Table 15: Europe Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Indication, 2015–2024
Table 16: Europe Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 17: Asia Pacific Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 18: Asia Pacific Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Drug Class, 2015–2024
Table 19: Asia Pacific Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Indication, 2015–2024
Table 20: Asia Pacific Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2024
Table 21: Middle East and Africa Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2024
Table 22: Middle East and Africa Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Drug Class, 2015–2024
Table 23: Middle East and Africa Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Indication, 2015–2024
Table 24: Middle East and Africa Neuropathic Pain Market Value (US$ Mn) Analysis and Forecast By Distribution


List of Figures

Figure 01: Global Neuropathic Pain Market Value Share By, Drug Class, 2015 A
Figure 02: Global Neuropathic Pain Market Value Share By, Drug Class, 2015 A
Figure 03: Global Neuropathic Pain Market Value Share By, Indication, 2015 A
Figure 04: Global Neuropathic Pain Market Value Share, By Region, 2015A 
Figure 05: Tricyclic Antidepressants Pricing Difference (US$) By Region, 2015 A
Figure 06: Anticonvulsants Drug Pricing Difference (US$) By Region, 2015 A
Figure 07: Local Anaesthesia Pricing Difference (US$) By Region, 2015 A
Figure 08: Opioid Pricing Difference Pricing Difference (US$) By Region, 2015 A
Figure 09: Global Neuropathic Pain Market Value (US$ Mn) & Y-o-Y Growth (%), 2015–2024
Figure 10: Global Neuropathic Pain Market Absolute $ Opportunity, 2016–2024
Figure 11: Global Neuropathic Pain Market Share and BPS Analysis (%) By Drug Class, 2016 & 2024
Figure 12: Global Neuropathic Pain Y-o-Y growth (%) By Drug Class, 2016–2024
Figure 13: Global Neuropathic Pain Market Absolute $ Opportunity By Tricyclic Antidepressants Segment, 2016–2024
Figure 14: Global Neuropathic Pain Market Absolute $ Opportunity By Anticonvulsants Segment, 2016–2024
Figure 15: Global Neuropathic Pain Market Absolute $ Opportunity By Local Anaesthetics Segment, 2016–2024
Figure 16: Global Neuropathic Pain Market Absolute $ Opportunity By Opioids Segment, 2016–2024 
Figure 17: Global Neuropathic Pain Market Absolute $ Opportunity By Steroids Segment, 2016–2024
Figure 18: Global Neuropathic Pain Market Absolute $ Opportunity By Other Drug Segment, 2016–
Figure 19: Global Neuropathic Pain Market Attractiveness Analysis By Drug Class, 2016–2024
Figure 20: Global Neuropathic Pain Market Share and BPS Analysis (%) By Indication, 2016 & 2024
Figure 21: Global Neuropathic Pain Market Y-o-Y Growth Rate (%) By Indication, 2016–2024
Figure 22: Global Neuropathic Pain Market Absolute $ Opportunity By CIPN, 2016–2024
Figure 23: Global Neuropathic Pain Market Absolute $ Opportunity By Diabetic Neuropathy Segment, 2016–2024
Figure 24: Global Neuropathic Pain Market Absolute $ Opportunity By Other Segment, 2016–2024
Figure 25: Global Neuropathic Pain Market Attractiveness Analysis By Indication, 2016–2024
Figure 26: Neuropathic Pain Market Share Analysis (%) By Distribution Channel, 2016 & 2024
Figure 27: Global Neuropathic Pain Y-o-Y growth (%) By Distribution Channel, 2016–2024
Figure 28: Global Neuropathic Pain Market Absolute $ Opportunity By Retail Pharmacies Segment, 2016–2024
Figure 29: Global Neuropathic Pain Market Absolute $ Opportunity Drug Store Segment, 2016–2024
Figure 30: Global Neuropathic Pain Market Absolute $ Opportunity By Online Pharmacies Segment, 2016–2024
Figure 31: Global Neuropathic Pain Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 32: Global Neuropathic Pain Market Value (US$ Mn) and CAGR (%) By Region, 2015, 2020, and 2024
Figure 33: Global Neuropathic Pain Market Share Analysis (%) By Region, 2016 & 2024
Figure 34: Global Neuropathic Pain Y-o-Y growth (%) By Region, 2016–2024
Figure 35: North America Neuropathic Pain Market Absolute $ Opportunity, 2016–2024
Figure 36: Latin America Neuropathic Pain Market Absolute $ Opportunity, 2016–2024
Figure 37: Europe Neuropathic Pain Market Absolute $ Opportunity, 2016–2024
Figure 38: Asia Pacific Neuropathic Pain Market Absolute $ Opportunity, 2016–2024
Figure 39: Middle East and Africa Neuropathic Pain Market Absolute $ Opportunity, 2016–2024
Figure 40: Global Neuropathic Pain Market Attractiveness Analysis By Region, 2016–2024
Figure 41: North America Neuropathic Pain Market Share Analysis (%) By Country, 2016 & 2024
Figure 42: North America Neuropathic Pain Y-o-Y growth (%) By Country, 2016–2024
Figure 43: North America Neuropathic Pain Market Attractiveness Analysis By Drug Class, 2016–2024
Figure 44: North America Neuropathic Pain Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 45: North America Neuropathic Pain Market Attractiveness Analysis By Indication, 2016–2024
Figure 46: Latin America Neuropathic Pain Market Share Analysis (%) By Country, 2016 & 2024
Figure 47: Latin America Neuropathic Pain Y-o-Y growth (%) By Country, 2016–2024
Figure 48: Latin America Neuropathic Pain Market Attractiveness Analysis By Drug Class, 2016–2024
Figure 49: Latin America Neuropathic Pain Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 50: Latin America Neuropathic Pain Market Attractiveness Analysis By Indication, 2016–2024
Figure 51: Europe Neuropathic Pain Market Share Analysis (%) By Country, 2016 & 2024
Figure 52: Europe Neuropathic Pain Y-o-Y growth (%) By Country, 2016–2024
Figure 53: Europe Neuropathic Pain Market Attractiveness Analysis By Drug Class, 2016–2024
Figure 54: Europe Neuropathic Pain Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 55: Europe Neuropathic Pain Market Attractiveness Analysis By Indication, 2016–2024
Figure 56: Asia Pacific Neuropathic Pain Market Share Analysis (%) By Country, 2016 & 2024
Figure 57: Asia Pacific Neuropathic Pain Y-o-Y growth (%) By Country, 2016–2024
Figure 58: Asia Pacific Neuropathic Pain Market Attractiveness Analysis By Drug Class, 2016–2024
Figure 59: Asia Pacific Neuropathic Pain Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 60: Asia Pacific Neuropathic Pain Market Attractiveness Analysis By Indication, 2016–2024
Figure 61: Middle East and Africa Neuropathic Pain Market Share Analysis (%) By Country, 2016 & 2024
Figure 62: Middle East and Africa Neuropathic Pain Y-o-Y growth (%) By Country, 2016–2024
Figure 63: Middle East and Africa Neuropathic Pain Market Attractiveness Analysis By Drug Class, 2016–2024
Figure 64: Middle East and Africa Neuropathic Pain Market Attractiveness Analysis By Distribution Channel, 2016–2024
Figure 65: Middle East and Africa Neuropathic Pain Market Attractiveness Analysis By Indication, 2016–2024